Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma.
about
Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significanceThe pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.ALK gene alterations in cancer: biological aspects and therapeutic implications.Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin.High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphomaSilibinin: an old drug for hematological disorders.The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers.The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
P2860
Q33901136-E2D1803F-F771-47E4-8602-2424A87EDDB6Q34788271-9BA843B1-FACA-42B3-A764-ABAF5C4CCA2AQ37061428-A874A6AD-8703-4F75-8DBD-E9BB372F426DQ38101044-9B6781B5-104C-49B5-B3EA-7D88E677C590Q38767006-6F11BCDB-955C-4807-812E-02C0188C29C5Q38858006-BB9E6B7C-74AB-4EC3-B85E-42D6D718140DQ38996543-B8E9507B-3446-4B75-8655-52D894415A69Q41830810-2633C88B-5528-465D-A109-7FFF1A204740Q42372332-F50DEAA2-9634-4DDE-B352-D212E1610A16Q45747315-87719C68-98A7-4F92-8CE1-3A5DF8259440Q46553742-6BA47CDB-C04C-422C-A811-411E0D77CD21Q47107337-697A2635-E31E-40FA-BA88-3443770A7F03Q47134648-2CF7E658-F3C7-4015-93B0-C3A5015B1250Q54117760-B344C696-EC77-4D1A-B7B6-672A55FDAE9DQ55057314-09AAD44C-E101-4FC4-8B40-5F952F7FF8CF
P2860
Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@en
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@nl
type
label
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@en
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@nl
prefLabel
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@en
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Aberrant expression and biolog ...... naplastic large cell lymphoma.
@en
P2093
J D Pearson
P Gelebart
R J Ingham
S A Hegazy
P2860
P2888
P356
10.1038/BCJ.2012.27
P577
2012-08-10T00:00:00Z
P5875
P6179
1047458308